Senators Float 'Patent Thicket' Bill To Limit Generic Litigation
By Theresa Schliep · July 17, 2025, 6:48 PM EDT
A bill floated in the U.S. Senate would limit the use of so-called patent thickets that are asserted by major pharmaceutical companies in litigation to restrict generic competition....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login